Top Stories: Microsoft teams with Sophia Genetics on healthcare tools; Teladoc posts $611M in revenue in Q3
Sophia Genetics' data display module leverages Microsoft Azure services to provide AI and machine learning capabilities.
Photo: Al David Sacks/Getty Images
A new Microsoft partnership aims to enhance data interoperability with artificial intelligence and machine learning. What does this partnership entail? I'm Jeff Lagasse with Healthcare Finance News, and we'll dig into that and other big developments in this week's Top Stories, including Teladoc health posting better-than-expected revenue in the third quarter, and the Centers for Medicare and Medicaid Services issuing the 2023 Home Health Prospective Payment System Rate Update final rule.
For more news and features from Jeff Lagasse, visit Healthcare Finance News.
In this episode:
- Microsoft, Sophia Genetics team up to pursue data-driven medicine
- Teladoc stock rises after posting narrower loss in Q3
- CMS issues final payment rules for home health, infusion and ESRD
Talking Points
Microsoft will team with Sophia Genetics on a multiyear effort that will focus on developing and deploying next-generation healthcare tools that equalize data across silos, improve clinical workflows and elevate standards of care.
- The goal is to improve clinical outcomes and make patient care more personalized by connecting institutions, the companies said.
- Teladoc Health posted better-than-expected revenue in the third quarter, driven by the virtual care giant's direct-to-consumer mental health segment, BetterHelp.
- CMS estimates that Medicare payments to home health agencies in 2023 will increase in the aggregate by 0.7%, or $125 million, compared with 2022.
Twitter: @JELagasse
Email the writer: jeff.lagasse@himssmedia.com
